Zengwu Wang
Chinese Academy of Medical Sciences & Peking Union Medical College · 423 works · 8,781 citations · h-index 41
Top works
- Status of Hypertension in China
- Quality of primary health care in China: challenges and recommendations
- Registry and Survival Study in Chinese Patients With Idiopathic and Familial Pulmonary Arterial Hypertension
- Prevalence of Heart Failure and Left Ventricular Dysfunction in China: The China Hypertension Survey, 2012–2015
- Trends in Prevalence, Awareness, Treatment and Control of Hypertension in the Middle-Aged Population of China, 1992-1998
- Prevalence of overweight, obesity, abdominal obesity and obesity-related risk factors in southern China
- Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature
- Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies
- Survey on prevalence of hypertension in China: Background, aim, method and design
- Current Status of Endovascular Treatment for Acute Large Vessel Occlusion in China
- Hypertension Control in Community Health Centers Across China: Analysis of Antihypertensive Drug Treatment Patterns
- 2023 Chinese guideline for lipid management
- Optimal investment for an insurer: The martingale approach
- The Disease Burden of Atrial Fibrillation in China from a National Cross-sectional Survey
- Association of a Province-Wide Intervention With Salt Intake and Hypertension in Shandong Province, China, 2011-2016
- Summary of the 2022 Report on Cardiovascular Health and Diseases in China
- Current status and etiology of valvular heart disease in China: a population-based survey
- Prevalence of overweight and obesity in China: Results from a cross-sectional study of 441 thousand adults, 2012–2015
- The J wave and fragmented QRS complexes in inferior leads associated with sudden cardiac death in patients with chronic heart failure
- Consensus for HER2 alterations testing in non-small-cell lung cancer